PHATHOM PHARMACEUTICALS INC. - COMMON STOCK

Phathom Pharmaceuticals to Participate in Two Upcoming Investor Healthcare Conferences

12 Nov 2021 16:30:00 By Nasdaq GlobeNewswire

Phathom Pharmaceuticals Reports Third Quarter 2021 Results and Provides Key Clinical, Regulatory, and Business Updates

08 Nov 2021 08:00:02 By Nasdaq GlobeNewswire

Phathom Pharmaceuticals Withdraws Public Offering

27 Oct 2021 21:47:20 By Nasdaq GlobeNewswire

Phathom Pharmaceuticals Announces Proposed Public Offering of 5,000,000 Shares of Common Stock

26 Oct 2021 16:01:00 By Nasdaq GlobeNewswire

Phathom Pharmaceuticals Announces New Data at ACG 2021 Annual Scientific Meeting

24 Oct 2021 15:30:00 By Nasdaq GlobeNewswire

Phathom Pharmaceuticals Announces Positive Topline Results from PHALCON-EE Pivotal Phase 3 Erosive Esophagitis Trial

18 Oct 2021 07:00:00 By Nasdaq GlobeNewswire

Phathom Pharmaceuticals Announces Results from VONO-103, a Phase 1 Study Evaluating Gastric Acid Inhibition of Vonoprazan and Lansoprazole (PREVACID®)

27 Sep 2021 08:00:00 By Nasdaq GlobeNewswire

Phathom Pharmaceuticals Secures $200 Million Term Loan Facility from Hercules Capital

20 Sep 2021 08:00:01 By Nasdaq GlobeNewswire

Phathom Pharmaceuticals Submits Two NDAs to U.S. FDA for Vonoprazan-based Treatment Regimens for the Treatment of H. pylori Infection

08 Sep 2021 08:00:01 By Nasdaq GlobeNewswire

Phathom Pharmaceuticals to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference

31 Aug 2021 07:45:00 By Nasdaq GlobeNewswire

Phathom Pharmaceuticals Reports Second Quarter 2021 Results and Provides Update Regarding Key Clinical and Regulatory Milestones

10 Aug 2021 08:00:02 By Nasdaq GlobeNewswire

Phathom Pharmaceuticals Mourns the Loss of Chairman and Founder, Tadataka "Tachi" Yamada, M.D.

05 Aug 2021 07:30:01 By Nasdaq GlobeNewswire

Phathom Pharmaceuticals to Participate in the BMO Biopharma Spotlight Series: Innovation in GI

02 Aug 2021 08:30:00 By Nasdaq GlobeNewswire

Phathom Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference

25 May 2021 16:01:00 By Nasdaq GlobeNewswire

Phathom Pharmaceuticals Reports First Quarter 2021 Results and Provides Recent Business Updates

11 May 2021 08:00:04 By Nasdaq GlobeNewswire

Phathom Pharmaceuticals to Present at the Bank of America Securities 2021 Virtual Healthcare Conference

06 May 2021 17:48:26 By Nasdaq GlobeNewswire

Phathom Pharmaceuticals Announces Positive Topline Results from Pivotal Phase 3 Trial of Vonoprazan in Helicobacter pylori (H. pylori) Infection; Study Met All Primary and Secondary Endpoints

29 Apr 2021 16:01:00 By Nasdaq GlobeNewswire

Phathom Pharmaceuticals to Present at 20th Annual Needham Virtual Healthcare Conference

06 Apr 2021 08:00:02 By Nasdaq GlobeNewswire

Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Highlights Pipeline and Business Progress

30 Mar 2021 16:05:01 By Nasdaq GlobeNewswire

Phathom Pharmaceuticals Announces Completion of Patient Enrollment in Pivotal Phase 3 Helicobacter pylori (H. pylori) Trial

19 Jan 2021 08:30:00 By Nasdaq GlobeNewswire